【小分子】《Genentech》將利用《Ventus》旗下「ReSOLVE®」平台開發小分子藥物

 【小分子】《Genentech》將利用《Ventus》旗下「ReSOLVE®」平台開發小分子藥物

 文章出處  

Businesswire 

 

 原文標題  

Ventus Therapeutics Enters into a Collaboration and License Agreement with Genentech to Discover and Develop Small-Molecule Medicines Using Ventus' ReSOLVE® Platform 

 

 文章序號  

9772

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.